LYZZ Capital is a healthcare-dedicated venture capital and private equity firm, self-described as globally active, investing in talents, assets, and technologies with a focus on unmet medical needs.

LYZZ Capital

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Mobile Non Scaleable Content

Microsoft Exchange Online

Apache

Office 365 Mail

Apple Mobile Web App Capable

Co-Founder and Managing Partner

Kevin Li

Principal

Peter Haberz

Partner

Court Turner

Business Management

Eric Zhang

Xiakai Cheng

Founding Managing Partner

Microtech Medical is a Chinese medical equipment start-up developing and manufacturing medical devices.

Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases.

Mabworks is a gene engineering mab company.

Chipscreen is a integrated biotech company specialized in discovery and development of novel small molecule pharmaceuticals.

Investors Active in Phoenix, Arizona

Early Stage Venture Investors with Investments in Shanghai, Shanghai

Early Stage Venture Investors with Investments in West Coast (Top 10K)

Early Stage Venture Investors with Investments in Greater Boston Area

LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.

Shanghai

China

Asia

Onchilles Pharma Finds $7M For Cancer Drugs

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 1:52 PM	6f89cfc9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 1:52 PM	11bcd567
crunchbase trigger	general	Nov 19, 2024 1:52 PM	49eee649
crunchbase profile	general	Nov 20, 2024 11:05 AM	bacfcf0b
li profile	general	Nov 19, 2024 1:52 PM	fca6d632
translate crunchbase fundingrounds	general	Nov 20, 2024 11:43 AM	e1718938
peers	general	Nov 19, 2024 1:52 PM	92cef96d
news basic	general	Nov 19, 2024 1:52 PM	41359189
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

LYZZ

COM:LYZZCAP

LYZZ Capital